Figure 3.
Figure 3. Reduced efficacy of prophylactic FIXWT treatment in CRM+ compared with CRM− mice. SVBA evaluation of hemostasis 7 days after the infusion of 150 IU/kg of FIXWT in CRM− and CRM+ mice. Baseline SVBA in untreated CRM− (black) and CRM+ (orange) mice, CRM+ mice infused with FIXWT (green), CRM− mice infused with FIXWT (light green), and wild-type mice (red). Box plot rendition of the results showing the minimum, first quartile, median (waist), third quartile, and maximum values.

Reduced efficacy of prophylactic FIXWT treatment in CRM+ compared with CRM mice. SVBA evaluation of hemostasis 7 days after the infusion of 150 IU/kg of FIXWT in CRM and CRM+ mice. Baseline SVBA in untreated CRM (black) and CRM+ (orange) mice, CRM+ mice infused with FIXWT (green), CRM mice infused with FIXWT (light green), and wild-type mice (red). Box plot rendition of the results showing the minimum, first quartile, median (waist), third quartile, and maximum values.

Close Modal

or Create an Account

Close Modal
Close Modal